BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
US Army
Healthtrust
QuintilesIMS
US Department of Justice
Teva
Cerilliant
Merck
Fuji

Generated: January 18, 2018

DrugPatentWatch Database Preview

REGLAN Drug Profile

« Back to Dashboard

Which patents cover Reglan, and when can generic versions of Reglan launch?

Reglan is a drug marketed by West-ward Pharms Int, Robins Ah, Ani Pharms, and Meda Pharms. and is included in four NDAs. There are two patents protecting this drug.

The generic ingredient in REGLAN is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Drug patent expirations by year for REGLAN
Pharmacology for REGLAN
Medical Subject Heading (MeSH) Categories for REGLAN

US Patents and Regulatory Information for REGLAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms REGLAN ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021793-001 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ani Pharms REGLAN metoclopramide hydrochloride TABLET;ORAL 017854-002 May 5, 1987 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms REGLAN ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021793-002 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Robins Ah REGLAN metoclopramide hydrochloride SOLUTION;ORAL 018821-001 Mar 25, 1983 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms REGLAN ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021793-001 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ani Pharms REGLAN metoclopramide hydrochloride TABLET;ORAL 017854-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms REGLAN ODT metoclopramide hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021793-002 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for REGLAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
AstraZeneca
Medtronic
UBS
Farmers Insurance
Novartis
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot